Načítá se...
Eomesodermin increases survival and IL-2 responsiveness of tumor-specific CD8(+) T cells in an adoptive transfer model of cancer immunotherapy
Tumor-specific CD8(+) T cells often fail to elicit effective antitumor immune responses due to an inability to expand into a substantial effector population and persist long-term in vivo. Using an adoptive transfer model of cancer immunotherapy, we demonstrate that constitutive Eomes expression in t...
Uloženo v:
| Vydáno v: | J Immunother |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5801069/ https://ncbi.nlm.nih.gov/pubmed/29271784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000206 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|